CA-GREENPARK-SPORTS
16.12.2020 17:02:35 CET | Business Wire | Press release
GreenPark Sports , the fan-focused publisher and developer of mobile games and social experiences, has announced a global partnership with world-renowned Spanish soccer league LaLiga . GreenPark and LaLiga will work closely together in the multiyear deal to engage next-generation soccer fans in GreenPark’s virtual metaverse for sports and esports fans.
With the commitment to captivate local fan communities and networks, the partnership allows fans to select any of the league’s 20 teams as they flex their team spirit using their in-game avatar. As a GreenPark “superfan,” players will also be able to digitally outfit their avatar with authentic and custom LaLiga team gear, while participating in obstacle course runs, dance battles and various other minigames including some that leverage real-time scoring and statistics. In-game currency can also be exchanged for exclusive rewards and digital fan-gear.
“As one of the leading sports brands in the world, we continuously explore all the unique avenues to connect and engage with our fans globally. This partnership will let us get closer to the gaming community worldwide and offer them the possibility to follow the best soccer in the world, LaLiga” said Oscar Mayo, Head of Marketing and International Development at LaLiga. “We are confident that our partnership with GreenPark Sports will help us reach the next generation of fans by offering an exciting virtual arena for them to be a part of.”
Launching in early 2021, GreenPark Sports creates immersive social platforms for the new generation of sports and esports fans. The free-to-play mobile app will offer in-game experiences, allowing fans to battle it out through a variety of challenges and become the undisputed “Best Fans” of their league. Players can earn rewards virtually as well as exclusive tangible rewards.
“LaLiga represents some of the largest brands in all of sport, and the fueling passion from their fans is unparalleled,” said Tony Grillo, Vice President of Business Operations at GreenPark. “We look forward to co-creating special experiences for their fans and seeing them bring their energy into GreenPark!”
The new partnership follows GreenPark’s announcements with the National Basketball Association (NBA) earlier this month and the League of Legends Championship Series (LCS) in January.
To stay updated with the latest news on GreenPark Sports, follow the organization via its official website here , and on Twitter and Facebook .
Assets: GreenPark x LaLiga Partnership
ABOUT GREENPARK
Founded in 2018, GreenPark Sports is a publisher and developer of fan-forward, digital experiences and mobile games for the new generation of sports and esports fans. Co-founded by Chad Hurley (YouTube Co-founder / former CEO), Nick Swinmurn (Zappos founder / former CEO) and Ken Martin (BLITZ Co-founder / former CCO), GreenPark Sports was created to reimagine the role of today’s digitally-native fan as an active participant in the live sports/esports they love.
ABOUT LALIGA
LaLiga is a global, innovative and socially responsible organisation which is a leader in the leisure and entertainment sector. It is a private sports association composed of the 20 public limited sports companies (SADs) and clubs of LaLiga Santander and the 22 of LaLiga SmartBank, and is responsible for organising professional football competitions in Spain. In the 2019/20 season, LaLiga reached 2.8 billion people globally. With its headquarters in Madrid (Spain), it is present in 55 countries through eleven offices and 46 delegates. The organisation carries out its social work through its foundation and was the world's first professional football league to establish a league for intellectually challenged footballers: LaLiga Genuine Santander.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201216005356/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom